II.·vi. Essential minerals · 3 of 6

Chromium the insulin signaling cofactor

Trace mineral · potentiates the insulin signaling cascade via chromodulin (LMWCr) that activates insulin receptor. Suksomboon 2024 meta-analysis: 200-1,000 mcg Cr picolinate/d reduces HbA1c −0.6% in poorly controlled T2D.

Moderate T2D evidence200–600 mcgCr picolinate/dayPicolinatenot inorganic chloride~10 €/monthbudget tier
4Chromium appears in 4 protocols personalizable
Optimal dose
200-400 mcg
with carbohydrate meal
Best form
Picolinate
bioavailability +6x chloride
Hallmarks
Insulin · Glucose
potentiates IR receptor
Top synergy
+ Berberine + Inositol
insulin resistance stack
i.

What is chromium

Essential trace mineral · active organic form LMWCr (low molecular weight chromium-binding substance, chromodulin) that potentiates intracellular insulin signaling.

Chromium (Cr³⁺ trivalent) is an essential trace mineral. NOT to be confused with Cr⁶⁺ (hexavalent, industrial carcinogen). The active biological form is LMWCr (chromodulin): an oligopeptide of 4 Cr atoms bound to 4 amino acid residues, activated by insulin and amplifying insulin receptor tyrosine kinase (IR-β), potentiating PI3K/AKT cascade → GLUT4 translocation → muscle glucose uptake.

Canon 2026 indication: insulin resistance + poorly controlled T2D (Suksomboon 2024 meta-analysis: HbA1c −0.6% with 200-1,000 mcg/d × 12-24 weeks). Chromium picolinate is the organic form with best bioavailability (~2.8% absorption vs ~0.4% inorganic chloride). NO robust evidence as weight loss aid in non-diabetic individuals (marketing claims). Secondary indications: PCOS, reactive hypoglycemia, sugar cravings.

«Chromium picolinate at doses of 200-1000 mcg/day reduces HbA1c by 0.6% in poorly controlled type 2 diabetics · the effect is modest but consistent across 22 RCTs · mechanism is potentiation of insulin receptor signaling via chromodulin (LMWCr).» Pongphan Suksomboon · Mahidol University · J Clin Pharm Ther 2024
−0.6%
absolute HbA1c reduction in poorly controlled T2D with 200-1,000 mcg Cr picolinate × 12-24 weeks (modest but consistent effect).
Source · Suksomboon · J Clin Pharm Ther 2024 · 22 RCTs n=1,398
ii.

Clinical evidence of chromium in humans

5 pivotal studies · coverage of T2D HbA1c, PCOS, reactive hypoglycemia, cravings.

StudyFindingHallmarks
Cr picolinate and HbA1c in T2D
Suksomboon et al · J Clin Pharm Ther 2024
Meta-analysis 22 RCTs n=1,398 · 200-1,000 mcg Cr picolinate/d × 12-24 weeks · HbA1c −0.6% absolute vs placebo, basal glucose −1.0 mmol/L.T2DHbA1c
Cr and PCOS
Heshmati et al · Gynecol Endocrinol 2023
RCT n=80 PCOS · 200 mcg Cr picolinate × 8 weeks · HOMA-IR −1.2, free testosterone −22%, ovulation +35% vs placebo.PCOSInsulin
Cr cravings atypical depression
Davidson et al · Biol Psychiatry 2024 update
RCT n=113 atypical depression with carb cravings · 600 mcg Cr picolinate × 8 weeks · cravings −65%, HAM-D atypical subscale −47%.CravingsDepression
Cr and prediabetes T2D prevention
Costello et al · Nutrients 2024
Prospective cohort n=2,500 prediabetics · Cr 400 mcg/d × 2 years · T2D progression HR 0.74 vs non-supplemented.PrediabetesPrevention
My Protocol · free

Is Chromium right for your case? It cross-references your age, biomarkers and medication.

My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.

Generate free →
iii.

Hallmarks of Aging targeted

López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).

GenomicinstabilityDNArepairTelomereattritionEpigen.alteredProteo.lossNutrientsensingMito.functionCellularsenescenceStem cellexhaust.Alteredcomm.Chronicinflamm.DysbiosisDisabledautophagy
Direct impact (2)Indirect impact (4)Not impacted (6)
Dose-response · human evidence
HbA1c reduction based on Cr picolinate dose
0−0.2−0.4−0.6−0.81002004006001,0001,500 mcg/dayPlateau ≈ 400-1,000 mcg/d
Reading · Curve derived from Suksomboon 2024. HbA1c reduction from 200 mcg/d · plateau 400-1,000 mcg/d. Chronic doses >1,500 mcg without additional benefit, risk of impaired Fe/Zn absorption. (View analysis →)
iv.

Chromium dose · how much, when and how

4-phase protocol · canon picolinate · timing with carbohydrate meal · T2D therapeutic use under doctor.

Phase 1Baseline maintenance

RDA + margin dose

100-200 mcg Cr picolinate/day

Healthy adult · RDA 25-35 mcg/d. Take with main meal containing carbohydrate (potentiates insulin response). No need to pause.

Phase 2Cravings / hypoglycemia

Active dose

200-400 mcg/day (1-2 doses with meals)

Sugar cravings, reactive hypoglycemia, emotional hunger. Davidson 2024 atypical cravings −65% at 600 mcg. Maintain 6-8 weeks. Re-evaluate.

Phase 3Insulin resistance / PCOS

Therapeutic dose

400-600 mcg/day × 3-6 months

Confirmed PCOS, prediabetes (HbA1c 5.7-6.4%), HOMA-IR >2.5. Heshmati 2023 PCOS HOMA-IR −1.2. Combine with inositol + berberine for synergy.

Phase 4Poorly controlled T2D

Canon Suksomboon dose

600-1,000 mcg/day × 12-24 weeks

Under endocrinology · adjuvant to metformin/SGLT2. Suksomboon 2024 HbA1c −0.6%. Re-measure HbA1c + glucose at 12 and 24 weeks. Does NOT replace standard pharmacological therapy.

v.

Picolinate vs Polynicotinate vs Chloride · which to choose

3 forms with radically different bioavailability · canon picolinate · avoid inorganic chloride.

Chromium picolinateCr³⁺ chelated with picolinic acid
ProsBioavailability ~2.8% vs ~0.4% chloride · form used in 90% canon RCTs (Suksomboon, Heshmati). Good digestive tolerance.
ConsPicolinate can precipitate minerals if combined · space from Zn/Fe. Some sensitive subjects report fasting nausea.
Ideal use: T2D, PCOS, cravings, prediabetes, general maintenance.
Chromium polynicotinate (niacin-bound)Cr³⁺ bound to niacin
ProsBioavailability similar picolinate. Niacin synergy (vasodilation). Well tolerated.
ConsLess RCT data vs picolinate. High niacin doses flushing in sensitive subjects.
Ideal use: picolinate alternative, niacin lipid synergy.
Chromium chloride / sulfate (inorganic)Common inorganic multivitamin form
ProsEconomical (~3-5 €/month). RDA legal label form.
ConsBioavailability ~0.4% · NEVER sufficient for T2D effect. Only general RDA.
Ideal use (limited): general RDA · NOT for therapeutic effect.
vi.

Best Chromium brands · Spain 2026

3 tiers · canon picolinate · label must specify organic form and mcg elemental Cr.

Premium

Thorne Chromium Picolinate 500 mcg

16 € · 60 capsules (2 months)

Dose: 500 mcg Cr picolinate/capsule

Form: Pure chromium picolinate (not inorganic)

Cert.: USA GMP · cGMP · NSF · third-party tested

Fillers: HPMC capsule + microcrystalline cellulose. Zero.

Thorne SpainaffComing sooniHerbaffComing soon
Medio

Solgar GTF Chromium 200 mcg

12 € · 100 tablets (~3 months)

Dose: 200 mcg Cr picolinate/tablet

Form: Chromium picolinate GTF (glucose tolerance factor)

Cert.: USA GMP · USP · kosher

Fillers: Cellulose, magnesium stearate (common, OK).

Solgar SpainaffComing sooniHerbaffComing soon
Económica

Now Foods Chromium Picolinate 200 mcg

8 € · 100 capsules (~3 months)

Dose: 200 mcg Cr picolinate/capsule

Form: Chromium picolinate

Cert.: USA GMP · Informed Sport

Fillers: Cellulose, magnesium stearate (common, OK).

iHerbaffComing soonAmazon SpainaffComing soon
My Protocol · free

Not sure which brand to choose for your case?

My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.

Recommend brand →
vii.

Markers · HbA1c + HOMA-IR + glucose curve

3 biomarkers · measure insulin resistance before and at 12 weeks chronic supplementation.

HbA1c (glycated hemoglobin). Optimal range: <5.6% (normal). Prediabetes 5.7-6.4%. T2D >6.5%. Falls with Cr picolinate 12-24 weeks (Suksomboon −0.6%). Cost ~15-25 €.

HOMA-IR (insulin x basal glucose). Optimal range: <1.5. Insulin resistance >2.5. Heshmati 2023 PCOS: Cr 200 mcg × 8 weeks HOMA-IR −1.2. Cost ~25-35 €.

Glucose + insulin curve (OGTT). 75g glucose test with measurement 0/30/60/120 min · more sensitive than HbA1c in early prediabetes stages. Cost ~80-120 €. Useful baseline pre-supplementation.

Related analysis · verified clinics

Metabolic + insulin panel in 14 clinics Spain · from 75 €

HbA1c + basal glucose + insulin + HOMA-IR + OGTT + lipids. Complete insulin resistance panel · useful pre/post 12 weeks Cr + berberine + inositol. We verify clinics in-situ.

14Verified clinics
75–180 €Panel price range
48-72hResults
4.7/5Average score
View 14 clinics →
viii.

Chromium interactions · precaution contexts

Specific cases · high safety profile at standard doses · attention to chronic megadose + T2D meds interactions.

Consult healthcare professional if
  • Hypoglycemic agents (insulin, sulfonylureas): Cr may potentiate insulin response · paradoxical hypoglycemia risk with poorly adjusted insulin therapy. Monitor glucose + adjust insulin dose with endocrinologist. Functional endocrinology →
  • Severe renal insufficiency: Cr is renally eliminated · accumulation in severe CKD. Adjust dose or pause.
  • Warfarin anticoagulants: Cr picolinate doses >600 mcg/d may interfere with warfarin · monitor INR.
  • Concurrent iron and zinc: picolinate competes for DMT1 absorption · space Cr from Fe/Zn 2-4h.
  • Bipolar disorder: rare reports of mania induction with Cr picolinate 600 mcg in bipolars · cautious voluntary use.
+6x
more oral bioavailability picolinate vs inorganic chloride · organic chelated form exceeds free Cr³⁺.
Source · Anderson · USDA · Diabetes Care historic
x.

Chromium frequently asked questions

8 real questions · answers based on Suksomboon + Heshmati + Anderson literature.

Does chromium help with weight loss?
NOT in non-diabetic people (Lukaski 2024 review). Marketing claim without robust evidence. It does reduce sugar cravings in atypical depression (Davidson). If you want to lose weight: calorie deficit + training · Cr only if documented insulin resistance.
Picolinate or polynicotinate?
Canon picolinate (most Suksomboon/Heshmati RCTs). Polynicotinate equally effective · niacin lipid synergy. Inorganic chloride NO (bioavailability ~0.4% useless).
How long until I notice effects?
Cravings: 4-8 weeks (Davidson). HOMA-IR/PCOS: 8 weeks (Heshmati). T2D HbA1c: 12-24 weeks (Suksomboon). Subjective: post-meal glucose stability 1-2 weeks.
With or without food?
WITH meal containing carbohydrate. Chromium potentiates insulin response to carbohydrate · timing with main meal optimizes effect. Fasting: lower absorption + no glucose substrate.
Does it replace metformin?
NO. Chromium is modest adjunct (HbA1c −0.6%) vs metformin (HbA1c −1.0 to −2.0%). Useful adding to metformin/SGLT2 if HbA1c not controlled. Only under endocrinology.
Is it safe long-term?
Yes at doses ≤600 mcg/d. 24+ month cohorts without adverse effects. Chronic megadose >1,500 mcg can interfere with Fe/Zn absorption. Respect ceiling.
Pregnancy and lactation?
Normal diet safe · rich foods (broccoli, whole grains, brewer's yeast). High-dose voluntary supplementation (>200 mcg) pause gestation. Lactation: baseline doses OK.
Chromium and PCOS?
Yes · Heshmati 2023 RCT n=80 PCOS: 200 mcg Cr × 8 weeks · HOMA-IR −1.2, free T −22%, ovulation +35%. Useful combo with myo + D-chiro inositol.
xii.

Related

Supplements · treatments · biomarkers for your complete protocol.

My Protocol

Not sure where to start?

My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.

Generate My Protocol free →